Modern options of application of domperidone in gastroenterology
Abstract
The aim of review. To carry out analysis of the publications devoted to application of prokinetic drug domperidone (D) at various gastroenterological diseases.
Key points. Literature data demonstrate, that dopamine receptor antagonist D is effective drug for treatment of such diseases, as functional dyspepsia, diabetic and idiopathic gastroparesis, gastroesophageal reflux disease (within combined treatment modes), and for relief of nausea and vomiting, caused by cytotoxic agents as well. Side effects at application of D are determined by risk of hyperprolactinemia, which rarely clinically relevant.
Conclusion. Domperidone can be successfully applied for treatment of gastroenterological diseases accompanying primary or secondary disorders of stomach and duodenum motility.
About the Author
A. A. Sheptulin
ГБОУ ВПО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздравсоцразвития РФ
Russian Federation
Russian Federation
References
1. Ивашкин В.Т., Шептулин А.А. Методические рекомендации по обследованию и лечению больных с нарушениями двигательной функции желудка: Пособие для врачей. – М., 2003. – С. 1–30.
2. Ивашкин В.Т., Шептулин А.А., Киприанис В.А. Функциональная диспепсия. – М.: МЕДпресс-информ, 2011. – 112 с.
3. Рациональная фармакотерапия заболеваний органов пищеварения / Под ред. В.Т. Ивашкина. – 2-е изд. – М.: Литтерра, 2011. – С. 49–58.
4. Шептулин А.А. Прокинетический препарат мотилиум: фармакологические свойства и возможности клинического применения // Клин. мед. – 1997. – № 11. – С. 48–50.
5. Brogden R., Carmine A., Heel R. et al. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as antiemetic // Drugs. – 1982. – Vol. 24. – P. 360–400.
6. Dabоul I., Taleb N., Alkheshen M., Abell T.L. Domperidone decreases the average daily insulin requirement in patients with diabetic gastropathy // Neurogastroenterol. Motil. – 2000. – Vоl. 12. – P. 480.
7. Hiyama T., Yoshihara M., Matsuo K. еt al. Metaanalysis of the effects of prokinetic agents in patients with functional dyspepsia // J. Gastroenterol. Hepatol.– 2007. – Vol. 22. – P. 304–310.
8. Karamanolis G., Tack J. Promotility medications – now and in the future // Dig. Dis. – 2006. – Vol. 24. – P. 297–307.
9. Malfertheiner P. Gastroesophageale Refluxkrankheit // Falk Gastro-Kolleg. – 2009. – N 2. – S. 21–41.
10. Michiels M., Hendriks R., Heykants J. On the pharmacokinetics of domperidone in animals and man. II. Tissue distribution, placental and milk transfer of domperidone in the Wistar rat // Eur. J. Drug Metab. Pharmacokinet. – 1981. – Vol. 6. – P. 37–48.
11. Moayyedi P., Soo S., Deeks J. et al. Systemic review: Antacids, H 2-receptor antagonists, prokinetiks, bismuth and sucralfate therapy for non-ulcer dyspepsia // Aliment. Pharmacol. Ther. – 2003. – Vol. 17. – P. 1215–1227.
12. Paterson D., Abell T., Rothstein R. et al. Comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis // Am. J. Gastroenterol. – 1999. – Vol. 94. – P. 1230–1234.
13. Reddymasu S.C., Soykan I., McCallum W. Domperidone: review of pharmacology and clinical applications in gastroenterology. Clinical reviews // Am. J. Gastroenterol. – 2007. – Vol. 102. – P. 2036–2045.
14. Sawant P., Das H.S., Desai N. et al. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with nonulcer dyspepsia // J. Assoc. Physicians India. – 2004. – Vol. 52. – P. 626–628.
15. Sheng-Liang Chen, Jie-Ru J., Ping Hu. Effect of domperidone therapy on nocturnal dyspeptic symptoms of functional dyspepsia patients // World J. Gastroenterol. – 2010. – Vol. 16. – P. 613–617.
16. Tack J., Talley N.J., Camilleri M. et al. Functional gastroduodenal disorders // Gastroenterology. – 2006. – Vol. 130. – P. 1466–1479.
17. Veldhuyzen van Zanten S.J., Jones M.J., Verlinden M., Talley N.J. Efficacy of cisapride and domperidone in functional dyspepsia: a meta-analysis // Am. J. Gastoenterol. – 2001. – Vol. 96. – P. 689–696.
18. Wolbrette D.L. Risk of proarrhythmia with class III antiarrhytmic agents: sex-based differences and other issues // Am. J. Cardiol. – 2003. – Vol. 91. – P. 39–44.
19. Wolfe M.M., Lowe R.C. Investing in the future of GERD // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl. 2). – P. 204–208.
Review
For citations:
Sheptulin A.A. Modern options of application of domperidone in gastroenterology. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2012;22(6):4-8. (In Russ.)
Views:
79
Email this article 
